A Cystic Fibrosis drug targeting the basic defect that causes the condition has been shown to be safe and effective in newborns aged four weeks and above, new research involving RCSI University of Medicine and Health Sciences and Children’s Health Ireland has found.
Top U.S. Health Agency Makes $25,000 Buyout Offer to Most of its Employees
Most of the 80,000 federal workers responsible for researching diseases, inspecting food, and administering Medicare and Medicaid under the auspices of the Department of Health
March 10, 2025